Skip to Content


In the US, Adefovir (adefovir systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent

Antiviral agent: Treatment of hepatitis B

Nucleotide reverse transcriptase inhibitor (NtRTI)

Chemical Name

[[2-(6-Amino-9H-purin-9-yl)etoxy]metyl]phosphonic acid (WHO)

Foreign Names

  • Adefovirum (Latin)
  • Adefovir (German)
  • Adéfovir (French)
  • Adefovir (Spanish)

Generic Names

  • Adefovir (OS: BAN, USAN)
  • GS 0393 (IS)
  • Adefovir Dipivoxil (OS: USAN, BANM)
  • Adefovir Pivoxil (OS: JAN)
  • Bis (pom) PMEA (IS)
  • GS 0840 (IS: GileadSciences)
  • Piv2 PMEA (IS)
  • Preveon (IS: Bristol-Myers)

Brand Names

  • Fodavir
    Eva, Egypt
  • Hepsera
    GlaxoSmithKline, Egypt
  • A Di Xian
    The United Laboratories Ltd, China
  • A Gan Ding
    Fujian Guangsheng Tang, China
  • Adefovir Dipivoxil
    SigmaPharm, United States
  • Adefovir Stada
    Stada-VN JV, Vietnam
  • Adepsera
    Green Cross, South Korea
  • Afoliva
    Samjin, South Korea
  • Ailuwei
    Changzheng-Xinkai, China
  • Antiva
    Square, Bangladesh
  • Biovir
    Ivax, Argentina
  • Dai Ding
    Tianjin Institute of Pharmaceutical Research Pharmaceutical, China
  • Dinghe
    Lukang, China
  • Hepcure
    CJ Cheiljedang, South Korea
  • Hepsera
    Gilead, Australia; Gilead, Belgium; Gilead, Canada; Gilead, Switzerland; Gilead, Czech Republic; Gilead, Germany; Gilead, Denmark; Gilead, Spain; Gilead, Finland; Gilead, France; Gilead, Greece; Gilead, Hungary; Gilead, Ireland; Gilead, Iceland; Gilead, Lithuania; Gilead, Norway; Gilead, New Zealand; Gilead, Poland; Gilead, Portugal; Gilead, Romania; Gilead, Sweden; Gilead, Slovenia; Gilead, Slovakia; Gilead, Turkey; Gilead, United States; Gilead Sciences, United Kingdom; Gilead Sciences, Italy; Gilead Sciences International, Austria; GlaxoSmithKline, Argentina; GlaxoSmithKline, China; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Japan; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Philippines; GlaxoSmithKline, Singapore; GlaxoSmithKline, Thailand; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Venezuela; GlaxoSmithKline, Vietnam; Patheon, Israel; Pliva, Slovenia
  • Hepsevir
    Dong-A, South Korea
  • Infovir
    Incepta, Bangladesh
  • Jiule
    Fovir Pharm, China
  • Lifuzhi
    Jiangsu TianShiLi BeiTe Pharmaceutical Co., Ltd., China
  • Ming Zheng
    Chia Tai Tianqing, China
  • Xinfunuo
    SL Pharm, China
  • Yilaifen
    Qilu, China
  • Youheding
    YSY Pharmaceutical, China
  • Yubao
    Xinghu Biochem Pharm, China


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.